Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB001 recombinant peptide spray in recurrent aphthous ulcers (Phase II)
CTR20231905Phase 2Completed
- Sponsor
- Zhejiang Yingkang Biopharmaceutical
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GB001 in aphthosis (RAS), sponsored by Zhejiang Yingkang Biopharmaceutical. Started Jul 2023; status: completed.
02
Drugs
GB001
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on CTR20231905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231905.